John W. Wilson
Mayo Clinic proceedings · 2012
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom John W. Wilson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from John W. Wilson's perspective
Ordered by how strongly the researchers John W. Wilson trusts endorse each paper. Same corpus, a different order for every researcher.
- Clinical and Laboratory Features of the Nocardia spp. Based on Current Molecular Taxonomy (Clinical Microbiology Reviews)
- Performance standards for antimicrobial susceptibility testing
- Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria (Clinical Microbiology Reviews)
- Nontuberculous mycobacteria and associated diseases. (American Review of Respiratory Disease)
- Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
- GRADE guidelines: 2. Framing the question and deciding on important outcomes. (Journal of Clinical Epidemiology)
- A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae (Antimicrobial Agents and Chemotherapy)
- Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. (American Journal of Respiratory and Critical Care Medicine)
- GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. (Journal of Clinical Epidemiology)
- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. (Clinical Infectious Diseases)
Their papers
- Nocardiosis: updates and clinical overview. (2012) — 689 citations